InMed Pharmaceuticals Azioni (NASDAQ: INM)

Ultime notizie per InMed Pharmaceuticals (NASDAQ:INM) Azioni

InMed Pharmaceuticals

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.

InMed Pharmaceuticals Inc. - Common Shares

InMed Pharmaceuticals Inc

INmune Bio Inc

InMode Ltd

Inca Minerals Ltd

iShares Intermediate Muni Income Active ETF

Canary Capital Group LLC is looking to introduce a new level of accessibility and framework to <a href="https://www.benzinga.com/crypto">crypto investing</a> by means of a recently submitted S-1 registration statement to the U.S. Securities and Exchange Commission. The resulting product, the Canary Staked CRO ETF, seeks to give investors access to the native token of Crypto.com, Cronos (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">CRO</a>), without having to directly hold or oversee the digital asset.
The ETF is constructed to replicate the market price of CRO, minus fund expenses, and adds a second stream of income-generating activity through staking some of its assets on the Cronos proof-of-stake blockchain. The staking process, usual in blockchain networks rewarding validators for securing the network, enables the fund to receive incremental rewards in CRO in addition to price appreciation, if any.
In order to calculate its daily net asset value (NAV), <a href="https://www.benzinga.com/etfs">the fund</a> will use a benchmark pricing approach that averages CRO prices from various crypto exchanges. The aim is to present a more accurate, fair-market valuation in an otherwise fragmented and volatile trading environment.
As the <a href="https://www.sec.gov/Archives/edgar/data/2069288/000199937125006858/canarycro-s1_053025.htm">filing </a>explains, this structure isn't backed by federal institutions like the FDIC—a detail that may matter to risk-averse investors.
In particular, the fund avoids leverage, derivatives, or lending of assets, a fairly conservative approach in crypto investing, where structured products tend to come with sophisticated financial engineering layered on top. This might be attractive to investors who want uncomplicated exposure with magnified risk.
The ETF filing extends the earlier partnership between Canary Capital and Crypto.com via the Canary CRO Trust to launch a regulated avenue for qualified U.S. investors to gain access to CRO in a custody structure.
If approved, the Canary Staked CRO ETF would be another incremental move in bringing traditional capital markets together with decentralized assets. It would provide a regulated, passive means of crypto exposure with the added benefit of built-in on-chain yield generation. Investors may see this as innovation or just iteration, but it is certainly another indication of crypto&#8217;s continued shift toward mainstream financial frameworks.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/etfs/specialty-etfs/25/05/45699802/from-meme-stocks-to-mature-moves-why-schd-might-be-a-good-bet-for-young-investors-for-passive-income-power">From Meme Stocks To Mature Moves: Why SCHD Might Be A Good Bet For Young Investors For Passive Income Power</a></li>
</ul>
Photo: chayanuphol/ Shutterstock.com

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$CRO

CRON

Canary Capital Seeks SEC Approval For Staked CRO ETF Offering Passive Crypto Exposure

Shares of Nvidia Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) are trading lower Friday after reports emerged that the Trump administration is preparing a new set of export restrictions aimed at <a href="https://www.benzinga.com/government/regulations/25/05/45676270/chinese-stocks-soar-as-us-court-blocks-trump-tariffs">China's tech sector. </a>
What To Know: The proposed rule would extend existing sanctions to include subsidiaries that are majority-owned by companies already on U.S. trade restriction lists, such as the Entity List and Military End-User list, <a href="https://www.bloomberg.com/news/articles/2025-05-30/us-plans-wider-china-tech-sanctions-with-subsidiary-crackdown?srnd=homepage-americas&amp;embedded-checkout=true">according to Bloomberg.</a>
The new rule is intended to close loopholes that allow sanctioned Chinese firms to continue operating through affiliated entities not currently subject to controls. The policy would apply a 50% ownership threshold and could be announced as early as June, although the timing and specific companies affected remain under review. U.S. officials are also reportedly considering adding new Chinese chipmakers, including Changxin Memory Technologies and parts of Semiconductor Manufacturing International Corp., to the list of targeted firms.
The move adds pressure to semiconductor stocks like Nvidia, which are exposed to the global chip supply chain and generate significant revenue from international markets. Tensions between the U.S. and China have escalated in recent weeks, following Trump's claim that China violated recent trade agreements and amid China's own restrictions on critical mineral exports.
Nvidia's decline reflects investor concerns over the potential impact of heightened export controls on chipmakers' access to Chinese markets, as well as broader uncertainty around U.S.-China tech policy.
NVDA Price Action: Nvidia shares were down 2.95% at $135.07 at the time of writing, according to <a href="http://www.benzinga.com/pro/register/?utm_source=BZprocontent072624&amp;t=be2bearmibe3na1">benzinga Pro.</a>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/05/45701116/wall-street-slumps-as-trump-reignites-china-trade-tensions-nvidia-wipes-out-earnings-rally-whats-driving-markets-friday">Wall Street Slumps As Trump Reignites China Trade Tensions, Nvidia Wipes Out Earnings Rally: What&#8217;s Driving Markets Friday? </a></li>
</ul>
Image Via Shutterstock.

News

Movers

NVDA

What's Going On With Nvidia Shares Today?

Wall Street analysts raised their price targets on Dell Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DELL#NYSE">DELL</a>) on Friday after the company reported its first-quarter <a href="https://www.benzinga.com/news/earnings/25/05/45681613/dell-q1-earnings-revenue-beat-eps-miss-company-highlights-unprecedented-demand-for-ai-optimized-servers">results on Thursday.</a>
Dell reported first-quarter revenue of $23.38 billion, up 5%, beating the consensus estimate of $23.14 billion. The company reported adjusted earnings of $1.55 per share, missing analyst estimates of $1.69 per share.
Also Read: <a target="_blank" href="https://www.benzinga.com/tech/25/05/45689336/dell-nvidia-to-build-next-gen-supercomputer-for-us-energy-department" rel="noreferrer noopener">Dell, Nvidia To Build Next-Gen Supercomputer For US Energy Department</a>
Dell expects second-quarter revenue of $28.5 billion-$29.5 billion. The company anticipates second-quarter adjusted earnings of $2.25. Dell expects fiscal 2026 revenue of $101 billion-$105 billion and full-year adjusted earnings of $9.40 per share.
<ul class="wp-block-list">
<li>Goldman Sachs analyst Michael Ng <a target="_blank" href="https://www.benzinga.com/quote/DELL/analyst-ratings" rel="noreferrer noopener">maintained a Buy</a> rating on Dell Technologies and raised the price target from $95 to $130.</li>
<li>BofA Securities analyst Wamsi Mohan reiterated a Buy rating on Dell Technologies and raised the price target from $150 to $155.</li>
</ul>
Goldman Sachs: AI server momentum and buybacks offset EPS miss and fiscal 2026 EBIT outlook cut on traditional servers, storage, and PCs, as per Ng. Dell&#8217;s first-quarter EPS and EBIT missed on worse-than-expected ISG profits, and the company lowered its fiscal 2026 EBIT outlook to $9.1 billion-$9.5 billion (versus $9.2 billion-$9.6 billion prior) on slower market growth assumptions across traditional servers, PCs, and storage, he noted. 
However, AI server KPIs were much better than expected, with Dell delivering a record $12.1 billion of AI server orders (versus Ng&#8217;s estimate of $7.2 billion), of which ~$7 billion should translate into revenue in the second quarter, the analyst said.
Ng noted that the 5-quarter AI server pipeline increased Q/Q, remains several multiples of the backlog, and includes many sovereign, AI cloud, and enterprise opportunities.
The analyst said ISG margins of 9.7% were missed (versus Ng estimate 10.8%) but were primarily related to traditional server customers and geographic mix (i.e., more large customers, less North America exposure) with no issues around AI server margins. Despite investor concerns on PC margins, CSG EBIT was in-line and the outlook was better-than-feared with Dell seeing deflationary commodity costs inclusive of tariffs, Ng noted.
Despite Dell&#8217;s fiscal 2026 EBIT guidance cut, it raised its EPS guidance by $0.10 to $9.15-$9.65 (versus $9.05-$9.55 prior) on better buybacks, the analyst said.
Ng&#8217;s fiscal 2026 revenue and EPS move to $108.3 billion and $9.30, from $102.8 billion and $9.13.
BofA Securities: Dell reported that first-quarter revenue beat expectations. Still, Mohan noted that EPS came in at the low end of the guide due to modest tariff impacts on CSG margins and slightly weaker growth from ISS.
The analyst said the second-quarter guide far exceeded Street expectations due to an incremental $5 billion in revenue from AI servers.
At the highest level, he noted the potential for Dell to deliver significantly higher AI server revenue over the next two years (&gt;$30 billion) with a substantial upside to EPS (&gt;$3).
Dell reported CSG segment revenue of $12.5 billion (+4.5% Y/Y), exceeding their guide of ~flat growth Y/Y, the analyst said.
Management noted they saw strong demand growth across SMB and enterprise customers, Mohan said.
Commercial far outperformed Consumer, as consumer revenue declined 19% due to competitive industry pricing, he said.
Mohan noted that Dell saw a &#8220;modest impact&#8221; on tariffs in the quarter but was able to absorb the impact and leave pricing unchanged for its customers. Management still expects that PC refresh will occur in fiscal 2026 and should drive low single-digit to mid-single-digit revenue growth in CSG.
He said the confidence in PC refresh is due to the abnormal age of the install base and recent indicators for Win 11 upgrades and upgrades to AI PCs.
Mohan noted that Dell&#8217;s AI server backlog stands at $14.4 billion, implying $12.1 billion in AI server orders and $1.8 billion in AI server revenue and shipments in the first quarter.
The analyst said that for the second quarter, Dell guided AI server shipments to $7 billion, well above expectations, and increased its fiscal guide to $15 billion-plus (versus just $15 billion prior).
He said management is confident in its ability to grow AI server revenue and drive incremental growth in operating profit dollars and cash flows.
For the second quarter, Mohan modeled AI server revenue ~in line with the shipment guide of $7 billion (+126% Y/Y, +289% Q/Q), Mohan noted.
Mohan&#8217;s fiscal 2026 revenue and EPS move to $105.0 billion and $9.40, from $103.2 billion and $9.16.
Price Actions: DELL stock is trading lower by 1.8% to $111.57 at last check Friday. 
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/tech/25/05/45677102/dell-hewlett-packard-super-micro-set-to-benefit-from-nvidias-ai-chip-ramp" target="_blank" rel="noreferrer noopener">Dell, Hewlett Packard, Super Micro Set To Benefit From Nvidia&#8217;s AI Chip Ramp</a></li>
</ul>
Photo: Gabriel Pahontu/Shutterstock

Reiteration

DELL

Dell Wins Wall Street Praise After $12 Billion AI Server Orders, Solid Commercial PC Demand

Alibaba Group Holding Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) shares are trading lower Friday after a combination of political and legal developments reignited concerns over <a href="https://www.benzinga.com/government/regulations/25/05/45676270/chinese-stocks-soar-as-us-court-blocks-trump-tariffs">U.S.-China trade relations.</a>
What To Know: On Thursday, President Donald Trump stated that China had violated its trade agreements with the United States. While he did not specify which terms were broken, his comments come as he continues to push for stricter trade enforcement. Shortly after his remarks, a U.S. federal appeals court temporarily reinstated most of the tariffs Trump had previously enacted using the International Emergency Economic Powers Act.
These tariffs had been struck down just a day earlier by a three-judge panel, which ruled that the International Emergency Economic Powers Act did not grant the president unlimited authority to impose tariffs. However, the Trump administration filed an appeal and the appellate court responded by putting the lower court's decision on hold, pending further review.
For Alibaba and other U.S.-listed Chinese companies, this legal uncertainty adds pressure. The stock had previously seen upward movement when the court initially blocked the tariffs, but that optimism quickly reversed. Investors are now reassessing risk, especially as Alibaba and peers like PDD Holdings and Baidu operate in a geopolitical environment prone to sudden shifts.
Earlier in May, China and the U.S. agreed to temporarily lower mutual tariffs for 90 days, with U.S. duties dropping from 145% to 30% and Chinese duties on American goods falling from 125% to 10%. That agreement provided short-term relief, but the recent court ruling and Trump's rhetoric suggest those reductions may be at risk if political dynamics change, especially with the upcoming election cycle.
BABA Price Action: Alibaba shares were down 2.78% at $113.92 at the time of writing, according to <a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2">Benzinga Pro.</a>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/05/45701116/wall-street-slumps-as-trump-reignites-china-trade-tensions-nvidia-wipes-out-earnings-rally-whats-driving-markets-friday">Wall Street Slumps As Trump Reignites China Trade Tensions, Nvidia Wipes Out Earnings Rally: What&#8217;s Driving Markets Friday? </a></li>
</ul>
Image Via Shutterstock.

BABA

What's Going On With Alibaba Shares Today?

<a target="_blank" href="https://www.benzinga.com/topic/chinese-stocks" rel="noreferrer noopener">US-listed Chinese stocks</a> Alibaba Group Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>),&nbsp;PDD Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>), and&nbsp;Baidu, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>) declined on Friday after U.S. President&nbsp;Donald Trump&nbsp;accused China of violating an agreement with the U.S. to ease tariffs in his Truth Social <a target="_blank" href="https://truthsocial.com/@realDonaldTrump/posts/114596705340367716" rel="noreferrer noopener">post</a>.
However, President Trump did not mention specifically how China violated the deal.
Chinese electric vehicle companies, including&nbsp;NIO Inc&nbsp;(NYSE:&nbsp;NIO) and&nbsp;XPeng Inc&nbsp;(NYSE:&nbsp;XPEV), also traded lower on Friday.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/asia/25/05/45692725/alibaba-and-baidu-turn-to-chinese-ai-chips-as-us-sanctions-squeeze-nvidia-supply" rel="noreferrer noopener">Alibaba And Baidu Turn To Chinese AI Chips As US Sanctions Squeeze Nvidia Supply</a>
On May 12, Beijing and Washington&nbsp;had agreed to lower&nbsp;tariffs on each other's products, temporarily offering relief to the stock market. The deal reduced U.S. levies of 145% on most Chinese imports to 30%, while China's 125% duties on U.S. goods will drop to 10% for 90 days.
On Wednesday, a&nbsp;federal court had <a target="_blank" href="https://www.benzinga.com/government/regulations/25/05/45676270/chinese-stocks-soar-as-us-court-blocks-trump-tariffs" rel="noreferrer noopener">invalidated&nbsp;global tariffs</a> enacted by Trump under the International Emergency Economic Powers Act.
A three-judge panel, with appointees from the Reagan, Obama, and Trump eras, ruled that the IEEPA doesn't give the president unlimited power to impose tariffs.
However, the order was appealed, and on Thursday, the federal appeals court in Washington reinstated the tariffs on foreign imports.
"The request for an immediate administrative stay is granted to the extent that the judgments and the permanent injunctions entered by the Court of International Trade in these cases are temporarily stayed until further notice while this court considers the motions papers," the order stated,
Price Actions:&nbsp;BABA stock is down 2.88% at $113.81 at last check Friday. PDD is down 1.34%, BIDU is down 2.41.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/media/25/05/45679204/apple-iphone-shipment-could-decline-in-2025-as-tariff-competition-play-spoil-sport-idc" target="_blank" rel="noreferrer noopener">Apple iPhone Shipment Could Decline In 2025 As Tariff, Competition Play Spoil Sport: IDC</a></li>
</ul>
Photo by DOERS via Shutterstock

Government

Tech

BIDU

Citigourp Global Markets 2% Protected Notes Linked To The Djia

US Listed Chinese Stocks Drop After Trump Renews Trade Tensions

Golden Eagle Strategies filed with the U.S. Securities and Exchange Commission (SEC) to introduce a new <a href="https://www.benzinga.com/etfs">ETF centered</a> on some of the fastest-growing companies. 
The Golden Eagle Dynamic Hypergrowth ETF will be an actively managed fund that focuses on companies with at least 40% growth during the current quarter, and can comfortably be labeled as hypergrowth businesses.
The <a href="https://www.sec.gov/Archives/edgar/data/1771146/000199937125006852/golden-485apos_052925.htm#golden485aposa001">filing</a> on May 29, 2025, was identified by Bloomberg ETF analyst Eric Balchunas, who highlighted its heavy emphasis on high-growth stocks. Generally, firms in tech and innovation sectors are considered high-growth.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">New filing for the Golden Eagle Dynamic Hypergrowth ETF.. &quot;hypergrowth&quot; companies are defined as having YoY growth rate of at least 40% in the current quarter. (in case you wanted to know how back we were..) <a href="https://t.co/UdUeE2t91i">pic.twitter.com/UdUeE2t91i</a>
&mdash; Eric Balchunas (@EricBalchunas) <a href="https://twitter.com/EricBalchunas/status/1928203592348880925?ref_src=twsrc%5Etfw">May 29, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
The fund will come with an expense ratio of 0.85%. Golden Eagle Strategies has committed to absorbing most of the operational cost beyond the advisory fee, making it cost-effective for investors. The ETF should debut around mid-August 2025, pending regulatory approval, with exchange and ticker information still to be announced.
The timing of the announcement is significant. 
The tech sector, which was languishing in the markets most of the first five months of 2025, beaten by tariff and geopolitical worries, rebounded in May. This is reflected in the almost 8% monthly gains for the tech-heavy Nasdaq 100 index. Optimism around NVIDIA Corp.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) and Tesla Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) prospects <a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/25/05/45679047/nvda-tsla-turbocharge-qqq-surge-toward-best-month-since-2023">have a big role to play in this rise</a>. On a side note, the rebound has pushed the Invesco QQQ Trust (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which tracks the Nasdaq 100 index, to its best month since 2023.
From a trader&#8217;s point of view, the Golden Eagle Dynamic Hypergrowth ETF might offer an interesting play to both mainstream investors and those with access to innovation-driven growth. 
The fund&#8217;s emphasis on businesses that have extremely high growth rates, typically business areas aligned with technological advancements, may make it a favorite during the new generation of investment vehicles that are attempting to ride the surge in the technology sector.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/etfs/specialty-etfs/25/05/45699802/from-meme-stocks-to-mature-moves-why-schd-might-be-a-good-bet-for-young-investors-for-passive-income-power">From Meme Stocks To Mature Moves: Why SCHD Might Be A Good Bet For Young Investors For Passive Income Power</a></li>
</ul>
Photo: Shutterstock

New ETFs

TSLA

Golden Eagle Strategies Plans New ETF Targeting High-Growth Stocks During Tech Rebound

<a href="https://www.nj.gov/governor/news/news/562025/approved/20250530b.shtml" title="https://www.nj.gov/governor/news/news/562025/approved/20250530b.shtml">https://www.nj.gov/governor/news/news/562025/approved/20250530b.shtml</a>

'Governor Murphy and the Port Authority of New York and New Jersey Announce Runway Under Rehabilitation at Newark Liberty International Airport to Reopen Monday – 13 Days Ahead of Schedule' - State Of New Jersey

Cryptocurrency markets are down on Friday, with continued uncertainty over the future of tariffs depressing risk assets.
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>&nbsp;$104,722</td>
<td>-1.6%</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>&nbsp;$2,6570</td>
<td>-3.1%</td>
</tr>
<tr>
<td>Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)</td>
<td>&nbsp;$160.41</td>
<td>-5.0%</td>
</tr>
<tr>
<td>XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>)</td>
<td>&nbsp;$2.20</td>
<td>-3.7%</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>&nbsp;$0.1992</td>
<td>-9.4%</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>$0.0000131</td>
<td>-7.2%</td>
</tr>
</tbody>
</table>
</figure>
Notable Statistics:
<ul class="wp-block-list">
<li>IntoTheBlock data shows large transaction volume dropping by 18%, with daily active addresses down by 5%.</li>
<li>Coinglass data reports 269,555 traders were liquidated in the past 24 hours for $841 million.</li>
</ul>
Notable Developments:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/05/45701548/bitcoin-dips-below-104000-as-trump-media-raises-2-32-billion-to-build-btc-treasury">Bitcoin Dips Below $104,000 As Trump Media Raises $2.32 Billion To Build BTC Treasury</a></li>
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/05/45695347/bitcoin-hitting-1-million-by-2028-is-just-easy-with-these-3-policy-shifts-says-arthur-hayes">Bitcoin Hitting $1 Million By 2028 &#8216;Is Just Easy&#8217; With These 3 Policy Shifts, Says Arthur Hayes</a></li>
<li><a href="https://www.benzinga.com/cannabis/25/05/45692508/trump-administration-eyes-strategic-bitcoin-reserve-as-part-of-us-market-infrastructure-overhaul">Trump Administration Eyes Strategic Bitcoin Reserve As Part Of US Market Infrastructure Overhaul</a></li>
<li><a href="https://www.benzinga.com/cannabis/25/05/45691518/110m-wiped-out-bitcoin-whale-trader-gets-burned-as-btc-tags-104150">$110M Wiped Out: Bitcoin Whale Trader Gets Burned As BTC Tags $104,150</a></li>
</ul>
Trader Notes: Trade Mayne warns that Bitcoin must bounce around the $104,000 region or face a steeper drop below $100,000.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> Bounce from right here or we going sub $100k. <a href="https://t.co/JKCAXVmIv0">pic.twitter.com/JKCAXVmIv0</a>
&mdash; Mayne (@Tradermayne) <a href="https://twitter.com/Tradermayne/status/1928491766505726431?ref_src=twsrc%5Etfw">May 30, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Trader XO <a href="https://x.com/Trader_XO/status/1928493970574758063">sees</a> &#8220;sellers in control&#8221; and announces he would be interested in bidding the $102,000 region. 
Citrini Research <a href="https://x.com/Citrini7/status/1928178070793441733">highlighted</a> the inverse correlation between Bitcoin and treasuries, while Lookonchain pointed out that prominent whale trader James Wynn got <a href="https://x.com/lookonchain/status/1928491814270501052">liquidated again</a> on his long positions on Bitcoin and Pepe.
Market commentator Scott Melker shared a snippet from an interview with Vice President JD Vance, where the latter points out Bitcoin&#8217;s properties as a &#8220;store of value.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">&#x1f1fa;&#x1f1f8;VP JD VANCE SAYS <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> IS SECURE, SAFER FROM FRAUD, AND A STORE OF VALUE <a href="https://t.co/wZbWV3pcTA">pic.twitter.com/wZbWV3pcTA</a>
&mdash; The Wolf Of All Streets (@scottmelker) <a href="https://twitter.com/scottmelker/status/1928473757523366050?ref_src=twsrc%5Etfw">May 30, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45679277/how-strategys-052-bitcoin-correlation-drives-risk-asset-surge-report">How Strategy&#8217;s 0.52 Bitcoin Correlation Drives Risk Asset Surge: Report</a></li>
</ul>
Image: Shutterstock

$BTC

$DOGE

$ETH

$SHIB

$SOL

$XRP

Bitcoin, Ethereum, XRP, Dogecoin Can't Catch A Break As Traders See 'Sellers In Control'

Netflix Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFLX#NASDAQ">NFLX</a>) just earned a bullish call from Bank of America, which believes that even after a 33% year-to-date surge to all-time highs, the stock still <a href="https://www.benzinga.com/analyst-ratings/analyst-color">has more upside ahead.</a>
In a note shared Friday, analyst Jessica Reif Ehrlich said the streaming leader is benefiting from strong advertising momentum, a massive content slate and continued subscriber growth.
The investment bank lifted its price target on Netflix from $1,175 to $1,490, suggesting a 25% upside. 
<h3 class="wp-block-heading">Why Bank of America Is Bullish On Netflix</h3>
Netflix has been a top performer in the firm's coverage, supported by "sustained earnings momentum, positive subscriber trends," and a "defensive rotation related to tariffs."
At its recent 2025 Upfront presentation, Netflix reported that its ad-supported plan now reaches 94 million monthly active users—up from 70 million in November 2024 and 40 million one year ago.
Reif Ehrlich said the platform now delivers "more 18-34-year-olds than any U.S. broadcast or cable network," a milestone that significantly boosts its appeal to advertisers.
Netflix's move off Xandr and onto its own ad tech stack is proceeding smoothly. The company has already launched its in-house ad platform in the U.S. and Canada, and rollouts in 10 other ad markets are ongoing. The expert wrote that "long term, ads will be personalized and customized."
<h3 class="wp-block-heading">Second-Half Content Slate Could Boost Engagement</h3>
Netflix's second-half programming schedule is what Reif Ehrlich called a "content bonanza," featuring the return of its three most-watched franchises—&#8221;Squid Game&#8221; on June 27, &#8220;Wednesday&#8221; on August 6, and &#8220;Stranger Things&#8221; later this year.
These are joined by new originals like Guillermo del Toro's &#8220;Frankenstein,&#8221; Adam Sandler's &#8220;Happy Gilmore 2,&#8221; and Tina Fey's &#8220;The Four Seasons.&#8221;
On the live content front, Netflix is betting on boxing matches from Madison Square Garden—produced by Jake Paul's Most Valuable Promotions—and NFL games on Christmas Day.
Reif Ehrlich said this lineup supports &#8220;healthy retention and subscriber growth,&#8221; and positions Netflix for stronger ad engagement.
<h3 class="wp-block-heading">Netflix's Position Remains Strong</h3>
Reif Ehrlich lifted her valuation multiple from 32x to 40x expected 2026 EBITDA, in line with Netflix's current trading range. She said the move is backed by "increased visibility in growth drivers" including advertising and live programming.
"We continue to view Netflix as well positioned given the company's unmatched scale in streaming," Reif Ehrlich said, also pointing to "significant opportunities in advertising and sports/live."
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/05/45696827/bitcoin-banks-brokers-will-decide-next-big-market-move-says-bofas-hartnett">Bitcoin, Banks, Brokers Will Decide Next Big Market Move, Says BofA&#8217;s Hartnett </a></li>
</ul>
Photo: marekfromrzeszow / Shutterstock

Analyst Color

NFLX

Netflix Stock Could Climb Another 25% Thanks To Second-Half 'Content Bonanza,' Says Bank Of America

Goldman Sachs analyst Brooke Roach reiterated the Buy rating on Gap, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GAP#NYSE">GAP</a>), <a target="_blank" href="https://www.benzinga.com/quote/GAP/analyst-ratings" rel="noreferrer noopener">raising the price forecast from $25 to $28</a>.
On Thursday, the firm reported first-quarter earnings of&nbsp;51&nbsp;cents per share, which beat<a target="_blank" href="https://www.benzinga.com/news/earnings/25/05/45683620/gap-stock-plunges-after-q1-results-warns-tariffs-could-dent-fy25-revenue-by-150-million" rel="noreferrer noopener"> the consensus estimate of&nbsp;45&nbsp;cents</a>.
Quarterly revenue came in at $3.46 billion,&nbsp;which beat the Street estimate of&nbsp;$3.42 billion. Gap has reaffirmed its full-year 2025 guidance, excluding any potential tariff-related impacts.
While core business trends remain solid, the analyst highlighted that the investor sentiment may have been tempered by heightened expectations and Gap&#8217;s acknowledgment of a larger-than-expected tariff headwind in the second half, even after mitigation, estimated at $100 million to $150 million.
Also Read: <a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/25/05/45698047/gap-stock-is-falling-friday-whats-going-on" rel="noreferrer noopener">Gap Stock Is Falling Friday: What&#8217;s Going On?</a>
Gap continues to shift its sourcing strategy to reduce exposure to China. The company expects less than 3% of its products to come from China by the end of 2025, down from under 10% in 2024.
By the end of 2026, Gap aims to ensure no single country accounts for more than 25% of its sourcing.
The estimated unmitigated tariff impact stands at $250 million to $300 million, while mitigation efforts could bring that down to $100 million to $150 million. However, this range is not formally included in the company&#8217;s current outlook.
Gap is using standard mitigation levers such as adjusting sourcing, manufacturing, assortments, and negotiating with vendors, but does not plan to raise prices in response to the tariff risk.
Despite the uncertainty, the company is continuing to invest in key strategic initiatives and intends to reinvest a portion of its projected FY25 cost savings to support its growth plans.
While the analyst has reduced Gap&#8217;s second-half forecasts due to higher-than-expected tariff headwinds and expects this to weigh on the stock in the near term, Roach remained confident in the company&#8217;s ability to manage these challenges into FY26 using additional &#8220;mitigatory levers,&#8221; including the &#8220;unused option&#8221; of pricing.
The analyst added that Gap has additional mitigation tools available, including the option to adjust pricing, which it has not yet utilized.
Roach stated that their 2025, 2026, and 2027 EPS estimates have been revised to $2.19, $2.34, and $2.61, compared with the previous forecasts of $2.28, $2.37, and $2.61.
The update reflects Gap&#8217;s strong first-quarter performance and incorporates the latest tariff guidance provided by management, the analyst said in the note.
Price Action: GAP shares are trading lower by 18.2% to $22.87 at last check Friday.
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/05/45702396/can-burlingtons-profit-levers-deflect-tariff-impact-analysts-weigh-in" target="_blank" rel="noreferrer noopener">Can Burlington&#8217;s Profit Levers Deflect Tariff Impact? Analysts Weigh In</a></li>
</ul>
Photo via Shutterstock

Price Target

Analyst Ratings

GAP Flags Over $100 Million Tariff Burden Outside Guidance, Near-Term Stock Pressure Likely: Analyst

Trading in Lyft, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYFT#NASDAQ">LYFT</a>) is quiet Friday. But that may not be the case for long. There is a good chance the shares are <a href="https://www.benzinga.com/topic/ride-sharing">about to head lower</a>.
We have made Lyft our <a href="https://www.benzinga.com/topic/stock-of-the-day">Stock of the Day</a>. It may be breaking support. This is a bearish dynamic that could indicate the beginning of a new downtrend.
You can see on the chart that the shares have found support around $15.40. This level first became support in February 2024. It was also support in March and April 2024.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="575" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/30151712/one10-1024x575.png" alt="" class="wp-image-933734" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/30151712/one10-1024x575.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/30151712/one10-300x168.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/30151712/one10-768x431.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/30151712/one10.png 1438w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Then in February 2025, the level converted into resistance. This happened because of regretful buyers.
Many of the people who bought Lyft at the support regretted doing so when the stock dropped below it. Many decided to hold on to their losing positions. But they also decided that if they could ever exit at breakeven, they would.
Read Also: <a href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/05/45696827/bitcoin-banks-brokers-will-decide-next-big-market-move-says-bofas-hartnett" target="_blank" rel="noreferrer noopener">Bitcoin, Banks, Brokers Will Decide Next Big Market Move, Says BofA's Hartnett</a>
As a result, when the shares rallied back to $15.40 in February 2025, they placed sell orders. The large amount of these orders formed resistance at the same price that had been support.
Now Lyft has found support at this level again. This is because of seller's remorse.
Many of the traders and investors who sold at the resistance regretted doing so when the resistance broke and the stock moved higher. Some of them decided that if they eventually could, they would buy their shares back at the same price they were sold for.
So now that the price has fallen back to this level, these remorseful sellers are placing buy orders. The large concentration of these orders formed support at the same price that had been resistance.
But this support may be about to break.
When support breaks, it means the investors and traders who created the support with their buy orders are gone. They either finished or canceled their orders.
This means if new sellers enter the market, they will need to be aggressive and undercut each other if they want to draw buyers back into the market. If this happens, it could force the price of Lyft lower.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/05/45701116/wall-street-slumps-as-trump-reignites-china-trade-tensions-nvidia-wipes-out-earnings-rally-whats-driving-markets-friday">Wall Street Slumps As Trump Reignites China Trade Tensions, Nvidia Wipes Out Earnings Rally: What&#8217;s Driving Markets Friday?</a></li>
</ul>
Image: Shutterstock

Technicals

Trading Ideas

LYFT

Stock Of The Day: Is Lyft About To Breakdown?

WIIM

ABNB

ABNB stock has given up its prior loss. Airbnb shares were trading lower after Truist Securities downgraded the stock from Hold to Sell and cut its price target from $112 to $106.

Ulta Beauty Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULTA#NASDAQ">ULTA</a>) shares rallied in early trading on Friday, after the company reported on Thursday <a href="https://www.benzinga.com/news/earnings/25/05/45682895/ulta-beauty-stock-climbs-after-better-than-expected-q1-report-raised-fiscal-2025-outlook">upbeat first-quarter results</a>.
Here are some key analyst takeaways:
<ul class="wp-block-list">
<li>Piper Sandler <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/625eb91472b50e0001b1f6b5/korinne-wolfmeyer">analyst Korinne Wolfmeyer</a> maintained a Neutral rating, while raising the price target from $386 to $437.</li>
<li>Telsey Advisory Group <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5888c53977f9dd0001877a22/dana-telsey">analyst Dana Telsey</a> reaffirmed an Outperform rating, while raising the price target from $460 to $520.</li>
</ul>
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
Piper Sandler: Ulta Beauty's comp sales grew 2.9% year-on-year to $2,848 million, beating Street expectations of $2,794 million, Wolfmeyer said in a note. The company's brand engagement efforts seem to be "resonating" and proved effective in the quarter, she added.
Management's full-year guidance reflects the stronger first-quarter beat, while also incorporating more uncertainty in the back half of the year, the analyst stated. 
"While it does seem like management is taking a more conservative approach, we appreciate the prudence given the evolving macro backdrop," she further wrote.
Telsey Advisory Group: Ulta Beauty reported earnings of $6.70 per share, beating the consensus estimate of $5.81 per share, despite a challenging consumer environment, Telsey said. Management raised its full-year revenue guidance to $11.5-$11.7 billion, from their prior outlook of $11.5-$11.6 billion, she added.
The company had already indicated that this would be a transitional year, "marked by increased investments to help drive market share gains and long-term profitable growth," the analyst wrote.
ULTA Price Action: Shares of Ulta Beauty had risen by 11.38% to $469.81 at the time of publication on Friday.
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/cannabis/25/05/45689549/ulta-bets-on-category-depth-to-build-a-retail-media-empire-beauty-and-wellness-is-what-we-do">Ulta Bets On Category Depth To Build A Retail Media Empire: &#8216;Beauty And Wellness Is What We Do&#8217;</a></li>
</ul>
Photo: Shutterstock

Earnings Beats

ULTA

Ulta Beauty's Glow-Up: Retailer Beats Street, Raised Outlook Lifts Shares

<a href="https://www.wsj.com/economy/trade/u-s-china-trade-truce-risks-falling-apart-over-rare-earth-exports-c36ceb72" title="https://www.wsj.com/economy/trade/u-s-china-trade-truce-risks-falling-apart-over-rare-earth-exports-c36ceb72">https://www.wsj.com/economy/trade/u-s-china-trade-truce-risks-falling-apart-over-rare-earth-exports-c36ceb72</a>

Macro Economic Events

Global

Economics

Market Vectors Rare Earth/Strategic Metals Etf

REMX

'U.S.-China Trade Truce Risks Falling Apart Over Rare-Earth Exports; Agreement struck in Geneva centered on Beijing's promise to speed critical mineral export licenses' - WSJ

Pfizer Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>) on Friday released data from Phase 3 BREAKWATER trial evaluating BRAFTOVI&nbsp;(encorafenib) in combination with cetuximab (marketed as ERBITUX) and mFOLFOX6 (fluorouracil, leucovorin, and oxaliplatin) for metastatic colorectal cancer (mCRC) with <a target="_blank" href="https://www.benzinga.com/general/health-care" rel="noreferrer noopener">a&nbsp;</a><a target="_blank" href="https://www.benzinga.com/general/health-care" rel="noreferrer noopener">BRAF V600E</a><a target="_blank" href="https://www.benzinga.com/general/health-care" rel="noreferrer noopener"> mutation</a>.
The study showed statistically significant and clinically meaningful <a target="_blank" href="https://www.benzinga.com/pressreleases/25/05/b45691850/pfizers-braftovi-combination-regimen-cuts-the-risk-of-death-in-half-for-patients-with-braf-v600e-m" rel="noreferrer noopener">survival results</a>.
The data will be presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting and published in the&nbsp;New England Journal of Medicine.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/25/04/45073128/pfizers-covid-windfall-shrinks-expands-cost-cutting-efforts" rel="noreferrer noopener">Pfizer&#8217;s Covid Windfall Shrinks, Expands Cost-Cutting Efforts</a>
In a second interim analysis of overall survival (OS), a key secondary endpoint, the BRAFTOVI combination regimen reduced the risk of death by 51% compared to standard-of-care chemotherapy with or without bevacizumab (Hazard Ratio [HR] 0.49).
Median OS was 30.3 months with BRAFTOVI&nbsp;in combination with cetuximab and mFOLFOX6 compared to 15.1 months with chemotherapy with or without bevacizumab.
In the primary analysis of progression-free survival (PFS), the BRAFTOVI combination regimen reduced the risk of disease progression or death by 47% compared to standard-of-care chemotherapy with or without bevacizumab (HR 0.53) as assessed by blinded independent central review (BICR).
Median PFS was 12.8 months with the BRAFTOVI combination regimen compared to 7.1 months.
The updated objective response rate (ORR) by BICR confirmed the improvement previously observed with the BRAFTOVI combination regimen compared to patients receiving chemotherapy with or without bevacizumab.
The prior primary analysis also maintained the estimated median duration of response and median time to response.
The BRAFTOVI combination regimen received accelerated approval by the U.S. Food and Drug Administration (FDA) in December 2024 for patients with&nbsp;BRAF V600E -mutant mCRC based on a clinically meaningful and statistically significant improvement in confirmed ORR in treatment-naïve patients, the study&#8217;s other dual primary endpoint.
Continued approval for this indication is contingent upon verification of clinical benefit.
The BREAKWATER survival data are being discussed with the U.S. FDA to support potential conversion to full approval in 2025.
Price Action: PFE stock is up 0.51% at $23.57 at the last check on Friday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/general/health-care/25/05/45677512/alcon-secures-first-fda-approval-since-novartis-spin-off-in-2019" target="_blank" rel="noreferrer noopener">Alcon Secures First FDA Approval Since Novartis Spin-Off In 2019</a></li>
</ul>
Photo via Shutterstock

Health Care

Pfizer Reports Survival Gains In Colorectal Cancer Study, Combo Therapy Cuts Death Risk By Over 50%

Telsey Advisory Group analyst Cristina Fernandez maintained Foot Locker (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FL#NYSE">FL</a>) with a Market Perform and a <a target="_blank" href="https://www.benzinga.com/quote/FL/analyst-ratings" rel="noreferrer noopener">$24&nbsp;price target</a> on Thursday.
The earnings release disclosed total sales down 4.6% Y/Y to $1.79 billion versus the analyst estimate of negative 3.8% to $1.80 billion and FactSet at negative 2.1% to $1.83 billion due to store closures, the shutdown of several European countries, and an FX headwind of 10 bps, as per Fernandez.
The analyst noted that the pressure on the comp was due to soft traffic and was greater in the European business (which was down 10.2%), a deceleration from +1.9% in the fourth quarter of 2024.
Also Read: <a href="https://www.benzinga.com/news/earnings/25/05/45668653/foot-locker-quarterly-sales-slip-following-acquisition-deal" target="_blank" rel="noreferrer noopener">Foot Locker Quarterly Sales Slip Following Acquisition Deal</a>
<ul class="wp-block-list">
<li>The international comp was down 8.5%. </li>
<li>In North America, Foot Locker (-0.9%) and WSS (-4.6%) were dragged down performance and more than offset growth at Champs (+0.5%) and Kids Foot Locker (+3.4%).</li>
<li>The operating margin of -0.1% reflected a Y/Y decline of ~150 bps and was in line with the analyst&#8217;s expectation. </li>
<li>A gross margin decline of 40 bps to 28.4%, better than Fernandez at 28% and FactSet at 28.1%.</li>
</ul>
The company called out merchandise margin pressure of ~10 bps, likely on ongoing promotions, and occupancy deleverage of ~30 bps on the lower sales.
Given Dick&#8217;s Sporting Goods&#8217; pending acquisition, Foot Locker did not host an earnings call or update its prior financial outlook, which consisted of EPS of $1.35-$1.65, sales growth of -1.0% to 0.5%, a comp of 1.0%- 2.5%, and an operating margin of 2.6%- 3.1%.
Fernandez noted the pending acquisition of Foot Locker by Dick&#8217;s Sporting Goods as a good outcome for shareholders and does not expect significant regulatory opposition.
While Foot Locker has made progress on its LaceUp plan in areas like repositioning its store base through closures, off-mall openings, and refreshes and remodels, the analyst says there is much more work to do, with 300 refreshes and 80 remodels planned for 2025 and more in 2026.
While the company invested in technology, such as new apps, and relaunched its loyalty program, Fernandez said there is room for improvement.
While investors have been skeptical of the transaction, the analyst said Foot Locker could benefit from stronger supply chain and e-commerce capabilities and an experienced leadership team with a track record of execution under Dick&#8217;s Sporting Goods&#8217; ownership.
Over time, Fernandez noted Dick&#8217;s could generate greater savings through consolidation of operational functions, closing underperforming stores, divestitures of non-core banners, and adopting some of Dick&#8217;s best practices at Foot Locker, particularly as it relates to promotions, inventory management, and e-commerce. As per the analyst, these changes could allow Foot Locker to return to the 8.9% operating margin it generated in 2019 from ~2.3% in 2024.
Price Action:&nbsp;At the last check on Friday, FL shares were trading lower by 0.74% to $23.76.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/05/45655193/applovins-valuation-reflects-high-expectations-for-monetization-expansion-analyst" target="_blank" rel="noreferrer noopener">AppLovin&#8217;s Valuation Reflects High Expectations For Monetization Expansion: Analyst</a></li>
</ul>
Image: Shutterstock

Foot Locker To Rebound Under Dick's? This Analyst Says It Could

Synopsys, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNPS#NASDAQ">SNPS</a>) ordered its China employees to halt services and sales in the country effective May 29, 2025, after the new <a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/25/05/45657567/whats-going-on-with-synopsys-cadence-design-stocks-wednesday" rel="noreferrer noopener">U.S. export restrictions</a> kicked in, Reuters reported on Friday, citing an internal letter.
Products affected include semiconductor design software and chemicals.
This week, the U.S. ordered several companies to stop shipping goods to China without a license, and licenses, which had already been granted to specific suppliers, were revoked.
On Thursday, the company <a target="_blank" href="https://www.benzinga.com//node/45677138" rel="noreferrer noopener">disclosed that it received</a> a letter from the Bureau of Industry and Security of the U.S. Department of Commerce informing Synopsys of new export restrictions related to China and is ascertaining the potential impact. As a result, it suspended its third quarter outlook (Revenue $1.75 billion–$1.78 billion, Adj EPS $3.82-$3.87).
Also Read: <a target="_blank" href="https://www.benzinga.com/tech/25/05/45235394/nvidia-broadcom-lead-fund-manager-buys-even-as-semiconductor-sector-cools-analysts" rel="noreferrer noopener">Nvidia, Broadcom Lead Fund Manager Buys Even As Semiconductor Sector Cools: Analysts</a>
The U.S. sanctions prompted Chinese companies, including&nbsp;Alibaba Group Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>), to turn to <a target="_blank" href="https://www.benzinga.com/markets/asia/25/05/45692725/alibaba-and-baidu-turn-to-chinese-ai-chips-as-us-sanctions-squeeze-nvidia-supply" rel="noreferrer noopener">China-made AI</a> chips as U.S. export curbs cut&nbsp;Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) supply.
Synopsys, Cadence Design Systems, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDNS#NASDAQ">CDNS</a>), and Siemens&#8217; Mentor Graphics control over 70% of China&#8217;s electronic design automation (EDA) software market, which chipmakers can use to design semiconductors ranging from smartphones to computers and cars.
Synopsys stock lost over 19% in the last 12 months.
On Wednesday, Synopsys reported <a target="_blank" href="https://www.benzinga.com/news/earnings/25/05/45668888/synopsys-delivers-earnings-win-as-us-tech-export-curbs-loom-over-industry" rel="noreferrer noopener">second-quarter revenue</a> of&nbsp;$1.60&nbsp;billion, which aligns with the consensus estimate. The adjusted EPS of $3.67&nbsp;beat the street view of&nbsp;$3.38.
Price Action: SNPS shares are trading higher by 1.50% to $461.82 at last check Friday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/contracts/25/05/45702431/palantir-stock-gains-as-trump-expands-companys-role-in-us-government-agencies" target="_blank" rel="noreferrer noopener">Palantir Stock Gains As Trump Expands Company&#8217;s Role in US Government Agencies</a></li>
</ul>
Image Via Shutterstock

Regulations

Media

CDNS

SNPS

Synopsys Halts China Sales After US Cracks Down On Chip Design Exports

In the last three months, 15 analysts have published ratings on Hyatt Hotels (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/H#NYSE">H</a>), offering a diverse range of perspectives from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">8</td>
<td align="right">0</td>
<td align="right">2</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $137.8, a high estimate of $175.00, and a low estimate of $110.00. Observing a downward trend, the current average is 8.97% lower than the prior average price target of $151.38. 
<img src="https://www.benzinga.com/files/images/story/2025/1748631695_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
The standing of Hyatt Hotels among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Michael Bellisario</td>
<td>Baird</td>
<td>Raises</td>
<td>Neutral</td>
<td>$146.00</td>
<td>$142.00</td>
</tr>
<tr>
<td>Patrick Scholes</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$140.00</td>
<td>$156.00</td>
</tr>
<tr>
<td>Brandt Montour</td>
<td>Barclays</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$127.00</td>
<td>$122.00</td>
</tr>
<tr>
<td>Chad Beynon</td>
<td>Macquarie</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$150.00</td>
<td>$155.00</td>
</tr>
<tr>
<td>Lizzie Dove</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Sell</td>
<td>$123.00</td>
<td>$110.00</td>
</tr>
<tr>
<td>Duane Pfennigwerth</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$160.00</td>
<td>$175.00</td>
</tr>
<tr>
<td>Brandt Montour</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$122.00</td>
<td>$151.00</td>
</tr>
<tr>
<td>Stephen Grambling</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$112.00</td>
<td>$127.00</td>
</tr>
<tr>
<td>Simon Yarmak</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Hold</td>
<td>$132.00</td>
<td>$156.75</td>
</tr>
<tr>
<td>Lizzie Dove</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Sell</td>
<td>$110.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>David Katz</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Hold</td>
<td>$120.00</td>
<td>$161.00</td>
</tr>
<tr>
<td>Patrick Scholes</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$156.00</td>
<td>$163.00</td>
</tr>
<tr>
<td>Lizzie Dove</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$150.00</td>
<td>$170.00</td>
</tr>
<tr>
<td>Duane Pfennigwerth</td>
<td>Evercore ISI Group</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$175.00</td>
<td>$175.00</td>
</tr>
<tr>
<td>Stephen Grambling</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$144.00</td>
<td>$157.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Hyatt Hotels. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Hyatt Hotels compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Hyatt Hotels's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Hyatt Hotels's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/H/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Hyatt Hotels analyst ratings.</a>
<h2>Get to Know Hyatt Hotels Better</h2>
Hyatt is an operator of owned (3% of total rooms) and managed and franchised (97%) properties across about 30 upscale luxury brands, which includes vacation brands (Apple Leisure Group, Hyatt Ziva, and Hyatt Zilara), the recently launched full-service lifestyle brand Hyatt Centric, the soft lifestyle brand Unbound, the wellness brand Miraval, and the midscale extended-stay brand Studios. Hyatt acquired Two Roads Hospitality in 2018 and Apple Leisure Group in 2021. The regional exposure as a percentage of total rooms is 63% Americas, 15% rest of world, and 22% Asia-Pacific.
<h3>A Deep Dive into Hyatt Hotels's Financials</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Over the 3M period, Hyatt Hotels showcased positive performance, achieving a revenue growth rate of 0.23% as of 31 March, 2025. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Consumer Discretionary sector.
Net Margin: Hyatt Hotels's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of 1.16%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Hyatt Hotels's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 0.57%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Hyatt Hotels's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 0.15%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: With a below-average debt-to-equity ratio of 1.33, Hyatt Hotels adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>How Are Analyst Ratings Determined?</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Forecasting The Future: 15 Analyst Projections For Hyatt Hotels

Analysts' ratings for ServiceTitan (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTAN#NASDAQ">TTAN</a>) over the last quarter vary from bullish to bearish, as provided by 12 analysts.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">8</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $123.08, a high estimate of $140.00, and a low estimate of $90.00. This upward trend is evident, with the current average reflecting a 4.23% increase from the previous average price target of $118.09.
<img src="https://www.benzinga.com/files/images/story/2025/1748631685_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive ServiceTitan. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Parker Lane</td>
<td>Stifel</td>
<td>Raises</td>
<td>Buy</td>
<td>$125.00</td>
<td>$110.00</td>
</tr>
<tr>
<td>Andrew Sherman</td>
<td>TD Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$140.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Scott Berg</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$140.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>Jason Celino</td>
<td>Keybanc</td>
<td>Raises</td>
<td>Overweight</td>
<td>$140.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>David Hynes</td>
<td>Canaccord Genuity</td>
<td>Raises</td>
<td>Buy</td>
<td>$130.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Scott Berg</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$125.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>Andrew Sherman</td>
<td>TD Cowen</td>
<td>Announces</td>
<td>Buy</td>
<td>$120.00</td>
<td>-</td>
</tr>
<tr>
<td>Yun Kim</td>
<td>Loop Capital</td>
<td>Lowers</td>
<td>Hold</td>
<td>$90.00</td>
<td>$105.00</td>
</tr>
<tr>
<td>Parker Lane</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$110.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Scott Berg</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$125.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>Josh Baer</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$107.00</td>
<td>$104.00</td>
</tr>
<tr>
<td>Brent Bracelin</td>
<td>Piper Sandler</td>
<td>Maintains</td>
<td>Overweight</td>
<td>$125.00</td>
<td>$125.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to ServiceTitan. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of ServiceTitan compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for ServiceTitan's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Capture valuable insights into ServiceTitan's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/TTAN/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on ServiceTitan analyst ratings.</a>
<h2>Get to Know ServiceTitan Better</h2>
ServiceTitan Inc is an end-to-end technology platform built for contractors to transform the performance of their businesses. The Company's platform provides business owners, technicians, customer service representatives and other key office staff with technology tools designed to help customers grow revenue, drive operational efficiencies, deliver a superior end-customer experience and monitor key business drivers in real-time. The Company also has subsidiaries in Yerevan, Armenia and British Columbia, Canada that primarily serve as research and development and support centers.
<h3>Understanding the Numbers: ServiceTitan's Finances</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: ServiceTitan displayed positive results in 3M. As of 31 January, 2025, the company achieved a solid revenue growth rate of approximately 29.37%. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Information Technology sector.
Net Margin: ServiceTitan's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of -85.99%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): ServiceTitan's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of -41.0%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): ServiceTitan's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of -11.12%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: ServiceTitan's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.11.
<h2>The Basics of Analyst Ratings</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

TTAN

ServiceTitan Stock: A Deep Dive Into Analyst Perspectives (12 Ratings)

Analysts' ratings for ConocoPhillips (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COP#NYSE">COP</a>) over the last quarter vary from bullish to bearish, as provided by 17 analysts.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">12</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">6</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $113.71, along with a high estimate of $126.00 and a low estimate of $95.00. This current average has decreased by 7.02% from the previous average price target of $122.29. 
<img src="https://www.benzinga.com/files/images/story/2025/1748631676_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive ConocoPhillips. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Scott Hanold</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$115.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Kalei Akamine</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$106.00</td>
<td>$107.00</td>
</tr>
<tr>
<td>John Freeman</td>
<td>Raymond James</td>
<td>Raises</td>
<td>Outperform</td>
<td>$109.00</td>
<td>$103.00</td>
</tr>
<tr>
<td>Roger Read</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$113.00</td>
<td>$116.00</td>
</tr>
<tr>
<td>Ryan Todd</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$107.00</td>
<td>$114.00</td>
</tr>
<tr>
<td>Nitin Kumar</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$125.00</td>
<td>$127.00</td>
</tr>
<tr>
<td>Biju Perincheril</td>
<td>Susquehanna</td>
<td>Lowers</td>
<td>Positive</td>
<td>$114.00</td>
<td>$120.00</td>
</tr>
<tr>
<td>Devin McDermott</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$118.00</td>
<td>$116.00</td>
</tr>
<tr>
<td>Kalei Akamine</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$107.00</td>
<td>$138.00</td>
</tr>
<tr>
<td>Betty Jiang</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$120.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Josh Silverstein</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$111.00</td>
<td>$116.00</td>
</tr>
<tr>
<td>Roger Read</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$116.00</td>
<td>$131.00</td>
</tr>
<tr>
<td>Scott Hanold</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$120.00</td>
<td>$133.00</td>
</tr>
<tr>
<td>Paul Cheng</td>
<td>Scotiabank</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$95.00</td>
<td>$115.00</td>
</tr>
<tr>
<td>Josh Silverstein</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$116.00</td>
<td>$130.00</td>
</tr>
<tr>
<td>Devin McDermott</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$126.00</td>
<td>$131.00</td>
</tr>
<tr>
<td>Arun Jayaram</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$115.00</td>
<td>$127.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to ConocoPhillips. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of ConocoPhillips compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of ConocoPhillips's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
To gain a panoramic view of ConocoPhillips's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/COP/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on ConocoPhillips analyst ratings.</a>
<h2>All You Need to Know About ConocoPhillips</h2>
ConocoPhillips is a US-based independent exploration and production firm. In 2024, it produced 2.0 million barrels per day of oil and natural gas liquids and 3.4 billion cubic feet per day of natural gas, primarily from Alaska and the Lower 48 in the United States and Norway in Europe and several countries in Asia-Pacific and the Middle East. Proven reserves at year-end 2024 were 7.8 billion barrels of oil equivalent.
<h3>ConocoPhillips's Economic Impact: An Analysis</h3>
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Revenue Growth: Over the 3M period, ConocoPhillips showcased positive performance, achieving a revenue growth rate of 19.27% as of 31 March, 2025. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Energy sector.
Net Margin: ConocoPhillips's net margin excels beyond industry benchmarks, reaching 17.19%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): ConocoPhillips's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 4.37% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): ConocoPhillips's ROA stands out, surpassing industry averages. With an impressive ROA of 2.3%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: ConocoPhillips's debt-to-equity ratio is below the industry average at 0.36, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>How Are Analyst Ratings Determined?</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

17 Analysts Assess ConocoPhillips: What You Need To Know

Press Releases

Presenting on the Emerging Growth Conference 72 Day 1 on June 12 Register Now

Presenting on the Emerging Growth Conference 72 Day 2 on June 13 Register Now

The Rising Importance Of Minor Cannabinoids In The Growing Edible Market

InMed Demonstrates Encouraging Data For Its Cannabinoid INM-089 In Treating Dry AMD, An Ocular Disease With Rising Patient Numbers As National Population Ages

AAWH

ASPI

ATRA

BIXT

CLNN

CSE:KASH

CSE:TEX

CVKD

DBMM

FBRKF

GTRIF

IMRN

KASHF

LGMK

LGVN

MHUA

PERF

PSRHF

RERE

RGBP

SNES

SUGCF

TRGEF

TSXV:PLSR

TSXV:SUG

UMAC

Screenshot 2024-08-27 at 5.44.40 PM

Biotech

General

Screenshot 2024-07-18 at 5.31.04 PM

Cannabis

Markets

Screenshot 2024-05-06 at 5.34.20 PM

InMed (NASDAQ: INM) Developing Cannabinoids Analogs To Treat Alzheimer&#39;s – New Studies Showcase INM-901&#39;s Therapeutic Abilities

Comments

InMed Pharmaceuticals

Notizie

Ultime notizie per InMed Pharmaceuticals (NASDAQ:INM) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO